Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

(E)-2-[[3-(3-methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid

Base Information
  • Chemical Name:(E)-2-[[3-(3-methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid
  • CAS No.:1001288-58-9
  • Molecular Formula:C20H17NO5
  • Molecular Weight:351.4
  • Hs Code.:
  • UNII:C6V7ZU2NPR
  • ChEMBL ID:CHEMBL1075834
(E)-2-[[3-(3-methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid

Synonyms:FT011

Suppliers and Price of (E)-2-[[3-(3-methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • (E)-2-[[3-(3-Methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoicAcid
  • 0.5mg
  • $ 65.00
  • DC Chemicals
  • FT011 >98%
  • 250mg
  • $ 1100.00
  • DC Chemicals
  • FT011 >98%
  • 100mg
  • $ 600.00
  • DC Chemicals
  • FT011 >98%
  • 1g
  • $ 2200.00
  • Biorbyt Ltd
  • FT-011
  • 50 mg
  • $ 1101.60
  • Biorbyt Ltd
  • FT-011
  • 10 mg
  • $ 399.50
  • Biorbyt Ltd
  • FT-011
  • 5 mg
  • $ 324.70
Total 35 raw suppliers
Chemical Property of (E)-2-[[3-(3-methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid
Chemical Property:
  • PKA:3.45±0.36(Predicted) 
  • XLogP3:3.3
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:5
  • Rotatable Bond Count:7
  • Exact Mass:351.11067264
  • Heavy Atom Count:26
  • Complexity:564
Purity/Quality:

99%, *data from raw suppliers

(E)-2-[[3-(3-Methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoicAcid *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Canonical SMILES:COC1=C(C=CC(=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OCC#C
  • Isomeric SMILES:COC1=C(C=CC(=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OCC#C
  • Recent ClinicalTrials:Effects of FT011 in Systemic Sclerosis
  • Recent EU Clinical Trials:A phase II, randomised, double blind, placebo-controlled study of the pharmacokinetics, pharmacodynamic effects, and safety, of
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1001288-58-9